相关实验视频

Updated: Jul 9, 2025

Achieving Efficient Fragment Screening at XChem Facility at Diamond Light Source

Achieving Efficient Fragment Screening at XChem Facility at Diamond Light Source

Published on: May 29, 2021

科学化学:虚拟药物查的开放平台

Daniel Del Hoyo¹, Martin Salinas¹, Alba Lomas¹

¹National Center of Biotechnology (CNB-CSIC), Madrid 28049, Spain.

Journal of chemical information and modeling

|December 5, 2023

概括

Scipion-chem是虚拟药物查 (VDS) 的新平台,简化了计算药物发现. 它集成了11个插件用于VDS任务,提供可访问,可互操作和可追溯的工作流.

科学领域:

计算化学计算化学
药物发现药物发现药物发现
生物信息学是一种生物信息学.

背景情况:

虚拟药物查 (VDS) 通过计算方式减少了需要实验测试的分子数量.
现有的VDS方法侧重于受体结构 (基于结构) 或连接体特征 (基于连接体).
Scipion是一个工作流引擎,用于对生物巨分子的结构研究.

研究的目的:

介绍Scipion-chem,这是Scipion的一个新分支,专门为VDS设计.
为执行VDS工作流提供一个可访问,可互操作和可追踪的平台.
通过整合共同的VDS程序和开发共识协议来增强VDS.

主要方法:

从流行的VDS程序中集成11个插件到Scipion工作流引擎中.
开发共识协议,将多个VDS程序的结果结合起来,以提高预测的稳定性.
使用Scipion图形用户界面来执行和分析VDS任务.
确保不同软件包之间的互操作性,并跟踪所有中间文件,参数和用户决策.

主要成果:

通过其图形用户界面,Scipion-chem为VDS任务提供了一个统一的平台.
集成的插件可以执行标准的VDS程序.
共识协议通过结合多个VDS程序输出来提供更强大的预测.
Scipion-chem促进了无的软件互操作性,并保持了详细的审计轨迹.

结论:

Scipion-chem是一个全面且用户友好的虚拟药物查平台.
该平台通过集成工具和强大的预测方法来提高药物发现效率.
科学化学促进了VDS工作流中的可访问性,互操作性和可追溯性.
该软件是公开提供给研究人员进行成功的VDS.

更多相关视频

Biosensor-based High Throughput Biopanning and Bioinformatics Analysis Strategy for the Global Validation of Drug-protein Interactions

Biosensor-based High Throughput Biopanning and Bioinformatics Analysis Strategy for the Global Validation of Drug-protein Interactions

Published on: December 1, 2020

Workflow and Tools for Crystallographic Fragment Screening at the Helmholtz-Zentrum Berlin

Workflow and Tools for Crystallographic Fragment Screening at the Helmholtz-Zentrum Berlin

Published on: March 3, 2021

相关概念视频

Drug Discovery: Overview

Drug Discovery: Overview

Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...

Structure-Activity Relationships and Drug Design

Structure-Activity Relationships and Drug Design

Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...